<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01261819</url>
  </required_header>
  <id_info>
    <org_study_id>FH Project #2142-4860</org_study_id>
    <nct_id>NCT01261819</nct_id>
  </id_info>
  <brief_title>&quot;Laparoscopic&quot; Cystoscopy Versus Traditional Cystoscopy</brief_title>
  <official_title>&quot;Laparoscopic&quot; Cystoscopy Versus Traditional Cystoscopy in Patients Undergoing Minimally Invasive Hysterectomy: A Prospective Comparison Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AdventHealth</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AdventHealth</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aimed to compare the use of a transurethral laparoscope to the use of a traditional&#xD;
      cystoscope for evaluation of the bladder and ureters at the time of laparoscopic&#xD;
      hysterectomy. The hypothesis was that visual inspection of the bladder and ureters can be&#xD;
      done safely using a transurethral laparoscope, takes less time than traditional cystoscopy,&#xD;
      and is more cost effective than traditional cystoscopy.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">July 2009</completion_date>
  <primary_completion_date type="Actual">July 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time Required to Perform Procedure (in Seconds)</measure>
    <time_frame>During Procedure (Up to 15 minutes)</time_frame>
    <description>Time required to perform cystoscopy with a laparoscope or a cystoscope after laparoscopic hysterectomy.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">66</enrollment>
  <condition>Lower Urinary Tract Injury</condition>
  <arm_group>
    <arm_group_label>transurethral laparoscope</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>These patients had cystoscopy performed with the transurethral laparoscope.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional cystoscopy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>These patients had cystoscopy performed with the traditional cystoscope, which is considered to be the &quot;gold standard.&quot;</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>cystoscopy</intervention_name>
    <arm_group_label>Traditional cystoscopy</arm_group_label>
    <arm_group_label>transurethral laparoscope</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. any female patient scheduled for a laparoscopic supracervical hysterectomy (LSH) or&#xD;
             total laparoscopic hysterectomy (TLH) with or without adnexectomy for benign disease&#xD;
&#xD;
          2. able to comprehend and sign the informed consent form&#xD;
&#xD;
          3. able to provide clean-catch urine specimens&#xD;
&#xD;
          4. able to complete a urinary symptom questionnaire pre- and post-operatively&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. participants in another research protocol involving an investigational product 30 days&#xD;
             before planned randomization&#xD;
&#xD;
          2. pregnant women&#xD;
&#xD;
          3. patients undergoing concomitant incontinence or pelvic support procedures (e.g.&#xD;
             transvaginal tape, transobturator tape, pelvic organ prolapse surgery)&#xD;
&#xD;
          4. patients known to have a history of recurrent urinary tract infections&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Katherine Kratz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>AdventHealth</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Florida Hospital</name>
      <address>
        <city>Winter Park And Celebration</city>
        <state>Florida</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://pubmed.ncbi.nlm.nih.gov/22818539/</url>
    <description>Publication of study</description>
  </link>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>October 28, 2010</study_first_submitted>
  <study_first_submitted_qc>December 16, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 17, 2010</study_first_posted>
  <results_first_submitted>September 16, 2020</results_first_submitted>
  <results_first_submitted_qc>September 16, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">October 8, 2020</results_first_posted>
  <last_update_submitted>September 16, 2020</last_update_submitted>
  <last_update_submitted_qc>September 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 8, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>cystoscopy, minimally invasive hysterectomy</keyword>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Transurethral Laparoscope</title>
          <description>These patients had cystoscopy performed with the transurethral laparoscope.</description>
        </group>
        <group group_id="P2">
          <title>Traditional Cystoscopy</title>
          <description>These patients had cystoscopy performed with the traditional cystoscope, which is considered to be the &quot;gold standard.&quot;</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="33"/>
                <participants group_id="P2" count="33"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Transurethral Laparoscope</title>
          <description>These patients had cystoscopy performed with the transurethral laparoscope.&#xD;
cystoscopy</description>
        </group>
        <group group_id="B2">
          <title>Traditional Cystoscopy</title>
          <description>These patients had cystoscopy performed with the traditional cystoscope, which is considered to be the &quot;gold standard.&quot;&#xD;
cystoscopy</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="33"/>
            <count group_id="B2" value="33"/>
            <count group_id="B3" value="66"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="45.5" spread="6.33"/>
                    <measurement group_id="B2" value="44.5" spread="5.10"/>
                    <measurement group_id="B3" value="45" spread="5.72"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex/Gender, Customized</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="33"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="66"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>BMI</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.6" spread="6.65"/>
                    <measurement group_id="B2" value="27.1" spread="5.14"/>
                    <measurement group_id="B3" value="27.85" spread="5.90"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Smoker (%)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="3"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Time Required to Perform Procedure (in Seconds)</title>
        <description>Time required to perform cystoscopy with a laparoscope or a cystoscope after laparoscopic hysterectomy.</description>
        <time_frame>During Procedure (Up to 15 minutes)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Transurethral Laparoscope</title>
            <description>These patients had cystoscopy performed with the transurethral laparoscope.</description>
          </group>
          <group group_id="O2">
            <title>Traditional Cystoscopy</title>
            <description>These patients had cystoscopy performed with the traditional cystoscope, which is considered to be the &quot;gold standard.&quot;</description>
          </group>
        </group_list>
        <measure>
          <title>Time Required to Perform Procedure (in Seconds)</title>
          <description>Time required to perform cystoscopy with a laparoscope or a cystoscope after laparoscopic hysterectomy.</description>
          <units>seconds</units>
          <param>Mean</param>
          <dispersion>95% Confidence Interval</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="33"/>
                <count group_id="O2" value="33"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="137" lower_limit="21.1" upper_limit="249.9"/>
                    <measurement group_id="O2" value="451" lower_limit="204.63" upper_limit="697.37"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>Adverse event data was collected for the duration of the study January-July 2009, and up to 6 weeks after the surgical intervention for each subject.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Transurethral Laparoscope</title>
          <description>These patients had cystoscopy performed with the transurethral laparoscope.</description>
        </group>
        <group group_id="E2">
          <title>Traditional Cystoscopy</title>
          <description>These patients had cystoscopy performed with the traditional cystoscope, which is considered to be the &quot;gold standard.&quot;</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>3</frequency_threshold>
        <default_assessment>Systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="6" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Renal and urinary disorders</title>
            <event_list>
              <event>
                <sub_title>bladder discomfort/pain</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>hematoma</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="33"/>
              </event>
              <event>
                <sub_title>Postoperative Urinary Tract Infection (UTI)</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Reproductive system and breast disorders</title>
            <event_list>
              <event>
                <sub_title>Vaginal bleed</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="1" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>Trocar-site bleed</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="33"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="33"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Katherine Kratz, M.D.</name_or_title>
      <organization>Florida Hospital</organization>
      <email>katiegoodrich@gmail.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

